[Aspects of hypertension of endocrine and adrenal origin].
The authors discuss the results of observation of 269 patients with adrenal arterial hypertension 247 of whom underwent operation. The malignant hypertension syndrome developed in 39% of the patients. It is presumed that its development was caused by the combination of adrenal and renal affections as well as by specific hormonal shifts: relative norepinephrine hyperproduction and reduced intensity of catecholamine metabolism. In all groups of the patients with the malignant hypertension syndrome, a higher daily excretion of aldosterone and increased blood renin activity were also found. The character of the drug therapy and the late results of surgical treatment are discussed. A new variant of hyperaldosteronism, dexamethasone-inhibited form of aldosteroma, is described.
D000307:Adrenal Gland Diseases / Q000150:complications* / Q000401:mortality / Q000601:surgery; D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000401:mortality / Q000601:surgery; D000315:Adrenalectomy; D000328:Adult; D002908:Chronic Disease; D005260:Female; D006801:Humans; D006973:Hypertension / Q000209:etiology* / Q000401:mortality / Q000601:surgery; D006974:Hypertension, Malignant / Q000209:etiology / Q000401:mortality / Q000601:surgery; D008297:Male; D008875:Middle Aged
Nekotorye aspekty gipertenzii éndokrinno-nadpochechnikovogo geneza.